Abdallah, H.Y.; Ibrahim, M.E.; Abd El-Fadeal, N.M.; Ali, D.A.; Elsehrawy, G.G.; Badr, R.E.; Hassoba, H.M.
Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine. Diagnostics 2022, 12, 1560.
https://doi.org/10.3390/diagnostics12071560
AMA Style
Abdallah HY, Ibrahim ME, Abd El-Fadeal NM, Ali DA, Elsehrawy GG, Badr RE, Hassoba HM.
Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine. Diagnostics. 2022; 12(7):1560.
https://doi.org/10.3390/diagnostics12071560
Chicago/Turabian Style
Abdallah, Hoda Y., Maha E. Ibrahim, Noha M. Abd El-Fadeal, Dina A. Ali, Gehad G. Elsehrawy, Rasha E. Badr, and Howayda M. Hassoba.
2022. "Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine" Diagnostics 12, no. 7: 1560.
https://doi.org/10.3390/diagnostics12071560
APA Style
Abdallah, H. Y., Ibrahim, M. E., Abd El-Fadeal, N. M., Ali, D. A., Elsehrawy, G. G., Badr, R. E., & Hassoba, H. M.
(2022). Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine. Diagnostics, 12(7), 1560.
https://doi.org/10.3390/diagnostics12071560
